| Patents for C07D 257 - Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms (9,612) |
|---|
| 05/24/2006 | EP1658263A1 Novel aminobenzophenone compounds |
| 05/24/2006 | CN1775764A Chemical synthesizing method of tetrazole compound |
| 05/23/2006 | US7049306 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4. |
| 05/18/2006 | WO2006051751A1 Method for preparing 2-alkoxy-5-tetrazolyl-benzaldehyde compound |
| 05/18/2006 | WO2006051142A1 1-pyrazolylethyl-1,4,7,10-tetraazacyclododecane-4,7,10-triacetic acids and application of the gadolinium (iii) complexes thereof in clinical diagnosis |
| 05/18/2006 | US20060106256 e.g. 1-[(benzylamino)methyl]-3-(3,5-difluorophenyl)-2-({3-[(dipropylamino)carbonyl]benzoyl}amino)propyl 4-nitrophenyl carbonate; secretase inhibitors; neurodegenerative disorders; Alzheimer's, Parkinson's diseases, Down syndrom, Hereditary Cerebral Hemorrhage with Amyloidosis of the Dutch-Type |
| 05/18/2006 | US20060106072 Compounds having selective activity for Retinoid X Receptors, and means for modulation of processes mediated by Retinoid X Receptors |
| 05/17/2006 | EP1656370A2 Biaryl heterocyclic compounds and methods of making and using the same |
| 05/17/2006 | EP1656361A1 Piperazine with or-substituted phenyl group and their use as glyt1 inhibitors |
| 05/17/2006 | EP1656138A2 Substituted cycloalkyamine derivatives as modulators of chemokine receptor activity |
| 05/17/2006 | CN1772743A Antifungal compound and its prepn process and application |
| 05/16/2006 | US7045541 Compounds for the treatment of metabolic disorders |
| 05/16/2006 | US7045540 Selective estrogen receptor modulators |
| 05/16/2006 | US7045533 Such as naphthalen-1-yl-(4-pentyloxy-naphthalen-1-yl)-mehtane for treatment/prevention of diseases/conditions associated with cannobinoid receptor activation such as chronic pain, osteo- and rheumatoid arthritis, teno-synovitis and gout |
| 05/11/2006 | WO2006050444A1 Water-based synthesis of poly(tetrazoles) |
| 05/11/2006 | US20060100443 Valsartan benzyl ester is hydrolyzed with an excess alkali metal hydroxide; washed with an organic solvent; acidified and isolated |
| 05/10/2006 | EP1653960A2 Melanin concentrating hormone receptor antagonist |
| 05/10/2006 | EP1653950A2 Nitrooxy derivatives of losartan, valsatan, candesartan, telmisartan, eprosartan and olmesartan as angiotensin-ii receptor blockers for the treatment of cardiovascular diseases |
| 05/10/2006 | CN1255408C Method for synthesizing 3 (or8)-(1-methoxyethyl)-8-(or3)-(1-hydroxyethyl)-deuteroporphyrin IX |
| 05/09/2006 | US7041832 Processes for preparing losartan and losartan potassium |
| 05/09/2006 | US7041659 Compounds for the treatment of metabolic disorders |
| 05/04/2006 | WO2006046593A1 Benzene compound having 2 or more substituents |
| 05/04/2006 | WO2005097817A3 Process and reagents for oligonucleotide synthesis and purification |
| 05/04/2006 | US20060094768 Thiophene derivative ppar modulators |
| 05/03/2006 | CN1767823A Asthma and allergic inflammation modulators |
| 05/02/2006 | US7038060 Synthesis of 2-butyl-3-(2′-(1-trityl-1H-tetrazol-5-yl)biphenyl-4-yl)-1,3-diazaspiro[4.4]-non-ene-4-one |
| 05/02/2006 | US7038051 Imidazonaphthyridines |
| 05/02/2006 | US7037927 Amides that inhibit vanilloid receptor subtype 1 (VR1) receptor |
| 05/02/2006 | US7037910 Pyridazino[6,1-c ][1,2,4]triazin-4-ones; mediate physiological and psychotropic effects; antagonists; antiemetics; |
| 04/27/2006 | US20060089393 Heteroaryl substituted biphenyl derivatives as p38 kinase inhibitors |
| 04/27/2006 | US20060089334 Aminoalkylphosphonates and related compounds as edg receptor agonists |
| 04/26/2006 | EP1650198A1 Alkoxytetrazol-1-ylbenzaldehyde compound and process for producing the same |
| 04/26/2006 | EP1650197A1 Water-soluble tetrazolium compounds |
| 04/26/2006 | CN1763036A Novel potassium losartan crystal form |
| 04/26/2006 | CN1763017A Novel valsartan crystal form |
| 04/20/2006 | WO2005113513A3 Aryl sulfonamides |
| 04/20/2006 | WO2005030705A9 Inhibitors of histone deacetylase |
| 04/20/2006 | US20060084681 Substituted pyrazoles, compositions containing such compounds and methods of use |
| 04/20/2006 | US20060084634 treatment of gram positive, gram negative and antibiotic resistant infections; [4(R,S)-(4a alpha ,5a alpha ,12a alpha )]-4-(Dimethylamino)-7-(1H-Tetrazol-1-yl)-1,4,4a,5,5a,6,11,12a-octahydro-3,10,12,12a-tetrahydroxy-1,11-dioxo-2-naphthacenecarboxamide |
| 04/19/2006 | EP1646636A1 Process for the preparation of tetrazole derivatives from organo boron and organo aluminium azides |
| 04/19/2006 | EP1481002B1 Histogranin-like peptides and non-peptides, processes for their preparation and uses thereof |
| 04/18/2006 | CA2360943C N2-phenylamidine derivatives |
| 04/13/2006 | WO2006038606A1 Biaryl derivative |
| 04/13/2006 | WO2005087752A3 Substituted hydroxyethylamine aspartyl protease inhibitors |
| 04/13/2006 | US20060079506 Adamantyl acetamides as 11-beta hydroxysteroid dehydrogenase inhibitors |
| 04/13/2006 | US20060078503 1,4,7,10-Tetraazacyclododecane butyltriols, processes for their production and pharmaceutical agents containing them |
| 04/12/2006 | EP1644344A1 Method of preparing cis-8b-methyldecahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cis-decahydro-2a,4a,6a,8a-tetraazacyclopenta [fg]acenaphthylene, cyclene and functionalised cyclenes |
| 04/12/2006 | EP1644326A1 Cathepsin cysteine protease inhibitors |
| 04/12/2006 | EP1644325A2 Methods and compositions for treating amyloid-related diseases |
| 04/12/2006 | EP1311499B1 Bicyclic compounds as h3 receptor ligands |
| 04/12/2006 | CN1759113A Novel synthesis of irbesartan |
| 04/12/2006 | CN1759105A Insecticidal phthalamide derivatives |
| 04/12/2006 | CN1250735C Method for production of non-proteinogen L-amino acid by fermentation |
| 04/05/2006 | EP1641770A1 Synthesis of tris n-alkylated 1,4,7,10-tetraazacyclododecanes |
| 04/05/2006 | CN1249058C Perfluoroalkyl-containing complexes with sugar radicals, process for their production and their use |
| 04/04/2006 | US7022726 ω-cycloalkyl 17-heteroaryl prostaglandin E2 analogs as EP2-receptor agonists |
| 04/04/2006 | US7022717 Chemokine receptor binding heterocyclic compounds |
| 03/30/2006 | WO2005019211A3 Biaryl heterocyclic compounds and methods of making and using the same |
| 03/30/2006 | US20060069268 Process for the manufacture of valsartan |
| 03/30/2006 | US20060069255 Novel aryl ureido benzoic acid derivatives and their use |
| 03/30/2006 | US20060069249 For improving contrast of X-ray, ultrasound, radionuclide and magnetic resonance images |
| 03/30/2006 | US20060069129 Chemokine receptor binding heterocyclic compounds |
| 03/29/2006 | EP1638948A1 Diphenylurea derivatives and their use as chloride channel blockers |
| 03/29/2006 | EP1303270B1 Method for treating cryptorchidism |
| 03/29/2006 | EP1200395B1 Urea derivatives as inhibitors of ccr-3 receptor |
| 03/29/2006 | CN1753878A Trimeric macrocyclic substituted benzene derivatives |
| 03/29/2006 | CN1752088A Medicinal composition containing timeazoamine ester |
| 03/28/2006 | US7019148 Synthesis of irbesartan |
| 03/28/2006 | US7019033 For therapy of cancer and other proliferative diseases such as inflammation, psoriasis and restenosis, as well as stroke, heart failure, and immunodeficiency disorders |
| 03/28/2006 | US7019024 Pharmaceutical for treatment of neurological and neuropsychiatric disorders |
| 03/23/2006 | US20060063937 pathogenic form of amyloid beta polypeptides inhibitor; 2-(2-Fluoro-1,1'-biphenyl-4-yl)-2-methylpropanoic acid; nonsteroidal antiinflammatory agent, neuroprotectant, ; side effect reduction; cyclooxygenase inhibitor; Alzheimer's disease, cognition activator, neurogenerative disease |
| 03/23/2006 | US20060063820 2,6-dihalo-4-(3,3-dichloro-allyloxy)-benzylalcohole derivatives having insecticidal and acaricidal properties |
| 03/23/2006 | US20060063765 5-[({[({(2S)-4-[(3,4-dichlorophenyl)methyl]-2-morpholinyl}methyl)amino]carbonyl}amino)methyl]-N-methyl-3-furancarboxamide; free of N-{[4-(3,4-dichlorobenzyl)morpholin-2-yl]methyl}-N'-(2-furylmethyl)urea; CCR3/chemokine recetptor/ antagonists |
| 03/23/2006 | DE102004037366A1 5-Iodtetrazole 5-iodotetrazoles |
| 03/22/2006 | EP1637524A1 10-substituted 1-, 4, 7,-tris (carboxymethyl)-1,4,7,10-tetraazacyclo-dodecane derivative for use as contrast agents |
| 03/22/2006 | EP1029541B1 Therapeutic or prophylactic agent for glomerulopathy |
| 03/21/2006 | US7015331 A compound selected from the group consisting of 1,2,3-benzotriazol-2-yl-L-alanine, 5-carboxy-1,2,3-benzotriazol-2-yl-L-alanine, and 5-carboxy-1,2,3-benzotriazol-1-yl-L-alanine. |
| 03/21/2006 | CA2315220C Integrin receptor antagonists |
| 03/21/2006 | CA2242416C Sulfonated amino acid derivatives and metalloproteinase inhibitors containing the same |
| 03/16/2006 | WO2006029193A2 Process for preparing substituted tetrazoles from aminotetrazole |
| 03/16/2006 | US20060058395 Compounds useful for the treatment of diseases responsive to antiangiogenetic therapy |
| 03/14/2006 | US7012140 substituted tetraazacyclododecane ligand containing a macrocyclic ring and a paramagnetic lanthanide metal ion coordinated to the tetraazacyclod odecane ligand; coordinated geometry adjusts the water exchange rate of the contrast agent |
| 03/14/2006 | US7012098 Inhibitors of inducible nitric oxide synthase for chemoprevention and treatment of cancers |
| 03/14/2006 | US7012075 Cathepsin cysteine protease inhibitors |
| 03/14/2006 | US7012071 such as 4-(4-(2-Fluorobenzyloxy)phenyl)-4-oxobutyric acid; for treatment of insulin resistance syndrome, diabetes, hyperlipidemia, fatty liver disease, cachexia, obesity, atherosclerosis and arteriosclerosis |
| 03/09/2006 | WO2005121109A3 Novel antiviral macrocycle derivatives and metal complexes, incorporating bridged macrocycles |
| 03/09/2006 | WO2005105770A3 Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives |
| 03/09/2006 | US20060052374 Amino-tetrazole analogues and methods of use |
| 03/09/2006 | DE10231627B4 Heterozyklisch substituierte Benzoylharnstoffe und ihre Verwendung als Arzneimittel Heterocyclic unsubstituted benzoyl ureas and their use as a medicament |
| 03/08/2006 | EP1632470A2 Calcium receptor active molecules |
| 03/08/2006 | EP1631556A1 Pharmaceutical composition comprising valsartan |
| 03/08/2006 | EP1313721B1 Non-imidazole aryloxyalkylamines as h3 receptor ligands |
| 03/08/2006 | CN1244583C Tiemomium azoleamine-8-carboxylic acid ester and 8-amide derivatives, its synthesizing method and application in producing anticancer preparation |
| 03/02/2006 | WO2003062248A3 N-(benzyl)aminoalkylcarboxylates, phosphinates, phosphonates and tetrazoles as edg receptor agonists |
| 03/02/2006 | DE102004023093B3 Trimere makrocyclisch substituierte Halogen-Benzolderivate Trimeric macrocyclic substituted halogen-benzene derivatives |
| 03/02/2006 | CA2578409A1 A method for preparing irbesartan and intermediates thereof |
| 03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
| 02/28/2006 | US7005442 8-azaprostaglandin carbonate and thiocarbonate analogs as therapeutic agents |
| 02/28/2006 | US7005433 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
| 02/22/2006 | CN1738806A Oxo-azabicyclic compounds |